|
VIDEO: Dr. Dennis Slamon Discusses the Importance of Participating in Clinical Trials
http://www.cancer.ucla.edu/index.aspx?page=1280
HER2+ metastatic breast cancer, a particularly aggressive form of the disease, currently accounts for about one in every five breast cancer diagnoses. In this moving profile, HER2+ metastatic breast cancer survivor Dr. Kathy Bennett, who was diagnosed with the disease in 2008, and UCLA Jonsson Comprehensive Cancer Center researcher and Herceptin pioneer Dr. Dennis Slamon, discuss how clinical trials turn survivors and scientists into colleagues, uniting them in the search for a cure. From AACR News.
Watch the video.
__________________
Diagnosed 2007
Stage IIb Invasive Ductal Carcinoma, Pagets, 3 of 15 positive nodes
Traditional Treatment: Mastectomy and Axillary Node Dissection followed by Taxotere, 6 treatments and 1 year of Herceptin, no radiation
Former Chemo Ninja "Takizi Zukuchiri"
Additional treatments:
GP2 vaccine, San Antonio Med Ctr
Prescriptive Exercise for Cancer Patients
ENERGY Study, UCSD La Jolla
Reconstruction: TRAM flap, partial loss, Revision
The content of my posts are meant for informational purposes only. The medical information is intended for general information only and should not be used in any way to diagnose, treat, cure, or prevent disease
|
Threaded Mode